The present invention relates to compounds of formula (I), 1
which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the
prevention or treatment of diabetes, especially type II diabetes, as well
as hyperglycemia, syndrome X, hyperinsulinemia, .beta.-cell failure,
obesity, satiety disorders, atherosclerosis, and various immunomodulatory
diseases.
